Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Should you're 45 or older, it is time to discuss to your physician about #ColorectalCancer screening. Your choices may shock you. https://www.cdc.gov/colorectal-cancer/screening/index.html
#ColorectalCancer is...
Lori Wirth, MD, affiliate professor, drugs, Harvard Medical College; medical director, Heart for Head and Neck Cancers; Massachusetts Normal Hospital, discusses the section...
Rochester Regional Well being celebrated a model refresh on Wednesday afternoon with the promise to supply sturdy well being care by teamwork.
Chelsea Autovino...
